TY - JOUR
T1 - Breast cancer in Colombia
T2 - a growing challenge for the healthcare system
AU - Duarte, Carlos
AU - Salazar, Alejandro
AU - Strasser-Weippl, Kathrin
AU - de Vries, Esther
AU - Wiesner, Carolina
AU - Arango-Gutiérrez, Angélica
AU - Krush, Lindsay
AU - Goss, Paul E.
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
PY - 2021/2
Y1 - 2021/2
N2 - Aim: To provide a comprehensive overview of breast cancer in Colombia. Methods: Data on breast cancer in Colombia are scarce. We present incidence data from population-based cancer registries that represent 4 distinct regions of the country. Other data originate from non-governmental institutions and healthcare providers within Colombia, official sources, expert opinion, Colombian legislation, and the Cancer Mortality Atlas publishes by Colombian National Cancer Institute. Results: In Colombia, the age-standardized incidence rate remained relatively stable between 2012 and 2020 (43.1 to 47.8 cases per 100,000 women-years); Additionally, survival since 1995 has presented a substantial improvement from 65.7 to 72.1. In 33% of cases, the diagnosis of breast cancer was made in advanced stages, stage III or higher. The health demography survey conducted in 2015 showed that the participation in mammography screening in women aged 40 to 69 remains low 48.1%. Some limitations regarding access to early detection and diagnosis include economic strata, health insurance coverage, origin, and accessibility. On average, a 90-day period was reported from onset of symptoms to diagnosis of breast cancer. Conclusion: The first action towards improving outcomes in breast cancer should be to improve stage at diagnosis and timely access to care.
AB - Aim: To provide a comprehensive overview of breast cancer in Colombia. Methods: Data on breast cancer in Colombia are scarce. We present incidence data from population-based cancer registries that represent 4 distinct regions of the country. Other data originate from non-governmental institutions and healthcare providers within Colombia, official sources, expert opinion, Colombian legislation, and the Cancer Mortality Atlas publishes by Colombian National Cancer Institute. Results: In Colombia, the age-standardized incidence rate remained relatively stable between 2012 and 2020 (43.1 to 47.8 cases per 100,000 women-years); Additionally, survival since 1995 has presented a substantial improvement from 65.7 to 72.1. In 33% of cases, the diagnosis of breast cancer was made in advanced stages, stage III or higher. The health demography survey conducted in 2015 showed that the participation in mammography screening in women aged 40 to 69 remains low 48.1%. Some limitations regarding access to early detection and diagnosis include economic strata, health insurance coverage, origin, and accessibility. On average, a 90-day period was reported from onset of symptoms to diagnosis of breast cancer. Conclusion: The first action towards improving outcomes in breast cancer should be to improve stage at diagnosis and timely access to care.
KW - Access to health
KW - Breast cancer
KW - Colombia
KW - Health policies
KW - Public health
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85101206931&partnerID=8YFLogxK
U2 - 10.1007/s10549-020-06091-6
DO - 10.1007/s10549-020-06091-6
M3 - Review article
C2 - 33611666
AN - SCOPUS:85101206931
SN - 0167-6806
VL - 186
SP - 15
EP - 24
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 1
ER -